Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,389
datasets available to search
ShareScore release 0.9.0
Dataset results
1,389 results for “Bladder cancer”
Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach
ClinicalTrials.gov study NCT03702179. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
ClinicalTrials.gov study NCT05562791. IPD Sharing: YES. Countries: 1. Publications: 0.
Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer
ClinicalTrials.gov study NCT03063125. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PENK Methylation Test for Detecting Bladder Cancer
ClinicalTrials.gov study NCT05220189. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Near Infrared Fluorescence Imaging for Bladder Cancer Detection
ClinicalTrials.gov study NCT03058705. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy
ClinicalTrials.gov study NCT03294304. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Aschistosoma Haematobiumspecific microRNAas a Tumor Marker for Early Diagnosis and Prognosis of Bilharzial Bladder Cancer in Eygpt
ClinicalTrials.gov study NCT05697224. IPD Sharing: UNDECIDED. Countries: 0. Publications: 4.
Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo
ClinicalTrials.gov study NCT03421652. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 3 Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy
ClinicalTrials.gov study NCT07342517. IPD Sharing: NO. Countries: 0. Publications: 1.
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT03617913. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Gemcitabine Submucosal Injection for Preventing Recurrence in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized Trial
ClinicalTrials.gov study NCT07198451. IPD Sharing: YES. Countries: 0. Publications: 12.
Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin
ClinicalTrials.gov study NCT02030574. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Enzalutamide for Bladder Cancer Chemoprevention
ClinicalTrials.gov study NCT02605863. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Virtual Histology of the Bladder Wall for Bladder Cancer Staging
ClinicalTrials.gov study NCT04369560. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT07067749. IPD Sharing: YES. Countries: 1. Publications: 0.
Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)
ClinicalTrials.gov study NCT00598806. IPD Sharing: Not stated. Countries: 3. Publications: 0.
TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer
ClinicalTrials.gov study NCT03125226. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
ClinicalTrials.gov study NCT03628716. IPD Sharing: NO. Countries: 1. Publications: 0.
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT03081858. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall o
ClinicalTrials.gov study NCT03519256. IPD Sharing: Not stated. Countries: 15. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.